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Introduction
Hyperemesis gravidarum is defined as severe nausea
and vomiting persisting after the 14th week of pregnan-
cy; it is often characterized by dehydration, electrolyte
imbalance, ketonuria, and weight loss of more than 5%
of body weight [1]. The etiology is unknown, and it oc-
curs in about 2% of pregnancies [2]. Total parenteral
nutrition (TPN) has been used in patients with se-
vere hyperemesis gravidarum complicated with malnu-
trition. In addition to improving the maternal nutritional
status [3], it can also ensure an appropriate caloric
intake with better control of electrolytes. However, the
situation may become troublesome in patients who
simultaneously suffer from hyperemesis gravidarum,
malnutrition, and diabetes mellitus. Individuals like the
one in the present case are rarely reported in the litera-
ture. This report describes the beneficial use of TPN in
combination with other antiemetics and insulin in the
management of intrauterine growth restriction (IUGR)
in a pregnant woman with diabetes, complicated with
hyperemesis gravidarum.
Case Report
A 26-year-old nulliparous female experienced severe
nausea and vomiting from early in her pregnancy. She
had had insulin-dependent diabetes mellitus for 7 years.
SUMMARY
Objective: We report a case of a pregnant woman with diabetes, complicated with hyperemesis gravidarum,
malnutrition, and intrauterine growth restriction, who was treated beneficially with total parenteral nutrition.
Case Report: A 26-year-old diabetic nullipara complained of severe nausea and vomiting from early in her
pregnancy. Malnutrition developed at about 24 weeks of gestation. In spite of treatment with antiemetics,
antihistamine, and vitamin B6, the symptoms persisted, and intrauterine growth restriction eventually developed.
Total parenteral nutrition was commenced at 29 weeks of gestation. She delivered a healthy female neonate
with a birth body weight of 2,120 g at 36 weeks of gestation by cesarean section. Total parenteral nutrition
was gradually tapered off 1 week later, and the mother was discharged from hospital in good condition 10
days after delivery.
Conclusions: Total parenteral nutrition may be used to treat diabetic patients with hyperemesis gravidarum who
develop malnutrition causing intrauterine growth restriction. [Taiwanese J Obstet Gynecol 2004;43(1):42–45]
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Although she continuously used insulin, the disease was
not satisfactorily controlled from the first trimester
because of hyperemesis gravidarum and poor food
intake. She was admitted to our ward at 24 weeks’
gestation with evidence of malnutrition, including bri-
tle hair, flaccid muscle tone, dark skin over the cheeks
and eyes, and significant body weight loss.
A combination of antiemetics, antihistamine, and
vitamin B6 was initially administered, but the severe
nausea and vomiting persisted after temporary relief.
Both the neurologist and psychologist excluded
neurologic and psychologic problems. Serial albumin,
pre-albumin, and transferrin levels were measured as
references for maternal nutritional status (Figures 1 and
2), in combination with measurements of the triceps
skin fold, upper arm circumference, and abdominal cir-
cumference (Table 1). The estimated fetal weights at
29, 30, and 32 weeks of gestation were about 1,200 g,
1,300 g, and 1,400 g, respectively (Figure 3). Intra-
uterine growth restriction was anticipated at 29 weeks
of gestation, and TPN was administered (Table 2). Am-
niocentesis was performed at 35 weeks of gestation to
confirm fetal lung maturity.
The patient had an abdominal delivery at 36 weeks
of gestation and delivered a female neonate with a birth
body weight of 2,120 g, and Apgar scores of 7 and 9 at
1 minute and 5 minutes, respectively; there were no
neonatal complications. The placenta was intact and
weighed 320 g with no evidence of fatty infiltration. The
mother’s nausea and vomiting subsided, and her food
tolerance improved after delivery. TPN was slowly tapered
off and completely stopped 1 week later. The mother
was discharged from our hospital in good condition 10
days after delivery.
Discussion
The cause of hyperemesis gravidarum is poorly under-
stood. The pathogenesis may include physiologic factors
Table 1. Anthropometric measurements at different gestational ages
Gestational Maternal body Maternal abdominal Maternal upper arm
age (wk) weight (kg) circumference (cm) circumference (cm)
24 55 R: 22, L: 22
26 56 R: 22, L: 22
28 56.5 90
30 58 91
32 60 92.5
34 61.5 93
36 62 95
R = right; L = left.
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Figure 1. Levels of transferrin and pre-albumin during hospitali-
zation.
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Figure 2. Levels of albumin during hospitalization.
such as hormone or electrolyte imbalance, and gas-
trointestinal tract disturbance, as well as psychologic
factors [2]. Nausea and vomiting may vary from mild to
life-threatening conditions or even death [4]. It is esti-
mated that about 10% of patients vomit after the 16th
week, and only about 1% have symptoms of vomiting
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support of medical and nursing staff. For patients with
persistent severe nausea and vomiting in spite of
intravenous hydration, several pharmacologic or
alternative therapies have been investigated, including
the use of pyridoxine [8], antihistamines [9], steroids
[10], the serotonin antagonist ondansetron [11],
antiemetics [6], powdered ginger [12], and acupunc-
ture [13]. Intravenous hydration using isotonic fluids
with the addition of potassium should be supplement-
ed as needed since vomiting may cause hypokalemia.
The association in this patient of gastrointestinal symp-
toms and diabetic enteropathy needs to be clarified.
Prednisolone has been reported to be effective in the
treatment of hyperemesis [10]. It was found that women
who take corticosteroids are significantly less likely to
be readmitted to hospital than those who take pro-
methazine [14]. However, long-term use of steroids in
the management of hyperemesis gravidarum requires
further investigation.
One’s nutritional status can be assessed by means of
anthropometric measurements, including height, weight,
and percentage of body fat [15], and also by biochemical
assessment, which varies greatly in different studies.
Albumin, with a half-life of 20 days, may reflect a status
of chronic dietary deficiency and is less likely to be
affected by short-term food restriction than retinol-
binding protein, which has a half-life of only 12 hours
[16]. In our study, albumin, pre-albumin, and transferrin
were used to evaluate the patient’s nutritional status in
combination with measurements of the triceps skin
fold, upper arm circumference, and abdominal circum-
ference. Pre-albumin and transferrin were used to
evaluate more recent dietary inadequacies. With a half-
life of about 8 days, transferrin was used as a guide
during additional nutritional support. Pre-albumin, with
a half-life of about 2 days, reflects acute changes in
caloric and protein intakes [17]. As we observed, after
commencement of TPN at 29 weeks’ gestation, there
was a gradual rise in transferrin and pre-albumin levels
(Figure 1). The same result was observed about 2 weeks
later for the albumin level (Figure 2). The estimated fetal
weight dropped under the 10th percentile in the 32nd
week of gestation but continued to improve until deli-
very (Figure 3).
TPN during pregnancy has previously been reported
to be effective for reversing maternal malnutrition and
for promoting fetal growth [18]. However, several ma-
ternal complications of TPN have also been reported,
including pneumothorax, fungemia, venous thrombosis,
local infection, elevated liver enzyme levels, and fatty
infiltration of the placenta [6]. Therefore, TPN is usually
reserved as a last resort. The use of TPN did not affect
blood sugar control with insulin in this patient. It can
Table 2. Total parenteral nutrition content
Amino acid (g/L) 42.5
Nitrogen (g) 6.7
Glucose (mL) 250
Sodium (mmol/L) 30
Potassium (mmol/L) 30.3
Chloride (mmol/L) 46.5
Magnesium (mmol/L) 10
Calcium (mmol/L) 2
Phosphorus (mmol/L) 13.5
Acetate (mmol/L) 63
Zinc (mg) 12.35
MVI (mL) 0.7
Kilocalories 1,020
Kilocalories: nitrogen 152
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Figure 3. Estimated fetal weight under sonography with the
10th and 50th percentile curves during pregnancy (modified
from: Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC,
Hauth JC, Wenstrom KD, Williams JW, eds. Williams Obstetrics,
21st edition. McGraw-Hill Professional, 2001). CASE = the es-
timated fetal weight of this case.
after the 20th week of gestation [5]. Some obstetric
conditions have been shown to be correlated with
hyperemesis, such as gestational trophoblastic disease,
multiple gestations, and certain fetal anomalies,
especially triploidy (partial mole), trisomy 21, and
hydrops fetalis [6]. One of the most serious complica-
tions reported to be associated with hyperemesis is
Wernicke’s encephalopathy, which is characterized by
ophthalmoplegia, gate ataxia, and confusion [7].
Several management options for hyperemesis
gravidarum have been investigated, but a consensus on
a gold standard has never been reached. Since the
severity of hyperemesis gravidarum varies, different
approaches have been reported, all of which require the
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also ensure appropriate caloric intake and electrolyte
control [19]. In conclusion, there is no clear evidence
that hyperemesis gravidarum is related to diabetes
mellitus. The use of TPN in our case was beneficial to
both the mother and fetus. In spite of possible potential
complications, TPN may be considered for diabetic
patients with hyperemesis gravidarum who develop
malnutrition causing IUGR.
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